
Phio Pharmaceuticals Corp. PHIO
€ 1.08
-0.79%
Geschäftsbericht 2025
hinzugefügt 05.03.2026
Phio Pharmaceuticals Corp. ROE 2011-2026 | PHIO
ROE Jährlich Phio Pharmaceuticals Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.17 | -151.39 | -140.05 | -105.92 | -60.58 | -67.56 | -154.98 | -54.21 | -679.32 | -82.86 | -114.99 | -320.58 | -423.41 | -331.11 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -43.17 | -679.32 | -195.01 |
ROE Vierteljährlich Phio Pharmaceuticals Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -91.12 | -97.62 | -125.09 | -118.18 | -156.72 | -164.45 | -141.26 | -113.55 | -139.98 | -127.88 | -117.03 | -54.9 | -69.73 | -58.11 | -52.54 | -34.99 | -52.73 | -55.64 | -59.17 | -48.64 | -85.07 | -103.77 | -126.32 | -108.7 | -119.69 | -94.26 | -72.86 | -41.49 | -176.57 | -300.65 | -423.8 | -570.1 | -590.48 | -475.78 | -359.01 | -61.31 | -89.38 | -97.08 | -101.07 | -85.57 | -165.93 | -218.22 | -266.93 | -236.65 | -278.31 | -239.61 | -206.21 | -372.66 | -344.51 | -274.7 | -14.47 | 469.25 | 901.44 | 1305.49 | 1517.14 | - | 432.2 | 432.2 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1517.14 | -590.48 | -61.8 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | ||
|
AbbVie
ABBV
|
-55.54 | $ 209.63 | -0.71 % | $ 371 B | ||
|
Verastem
VSTM
|
-366.23 | $ 4.99 | -5.77 % | $ 346 M | ||
|
VistaGen Therapeutics
VTGN
|
-73.05 | $ 0.57 | -5.85 % | $ 17.6 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
Voyager Therapeutics
VYGR
|
-61.06 | $ 3.96 | -4.24 % | $ 232 M | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Aileron Therapeutics
ALRN
|
-294.78 | - | 10.36 % | $ 9.8 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Atreca
BCEL
|
-123.92 | - | -11.76 % | $ 5.79 M | ||
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
bluebird bio
BLUE
|
-108.93 | - | - | $ 546 M | ||
|
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Avid Bioservices
CDMO
|
-231.16 | - | - | $ 789 M | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-27.19 | $ 12.36 | -11.46 % | $ 1.88 B | ||
|
Wave Life Sciences Ltd.
WVE
|
-39.43 | $ 6.39 | 3.06 % | $ 1.08 B | ||
|
Xenetic Biosciences
XBIO
|
-36.25 | $ 2.78 | -0.71 % | $ 4.73 M | ||
|
BeiGene, Ltd.
BGNE
|
6.58 | - | 0.49 % | $ 251 B | ||
|
XBiotech
XBIT
|
-32.45 | $ 2.27 | -1.73 % | $ 69.2 M | ||
|
Xenon Pharmaceuticals
XENE
|
-31.04 | $ 54.44 | -1.96 % | $ 4.24 B | ||
|
Xeris Pharmaceuticals
XERS
|
4.05 | $ 5.41 | -2.87 % | $ 868 M | ||
|
X4 Pharmaceuticals
XFOR
|
-42.51 | $ 4.07 | -5.57 % | $ 172 M | ||
|
Xencor
XNCR
|
-14.46 | $ 11.4 | -7.43 % | $ 846 M | ||
|
XOMA Corporation
XOMA
|
37.78 | $ 29.93 | -1.97 % | $ 362 M | ||
|
22nd Century Group
XXII
|
-32.07 | $ 2.41 | -18.03 % | $ 444 K | ||
|
BioDelivery Sciences International
BDSI
|
45.18 | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
-207.61 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
-46.05 | - | - | $ 3.74 B | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-63.65 | $ 1.06 | -2.75 % | $ 21.7 M | ||
|
Enochian Biosciences
ENOB
|
833.76 | - | - | $ 40.5 M |